239 related articles for article (PubMed ID: 24958075)
1. Vaccine-preventable diseases in Europe: where do we stand?
Wicker S; Maltezou HC
Expert Rev Vaccines; 2014 Aug; 13(8):979-87. PubMed ID: 24958075
[TBL] [Abstract][Full Text] [Related]
2. The spread of vaccine-preventable diseases by international travellers: a public-health concern.
Gautret P; Botelho-Nevers E; Brouqui P; Parola P
Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():77-84. PubMed ID: 22862565
[TBL] [Abstract][Full Text] [Related]
3. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2003 to 2006.
Menzies R; Turnour C; Chiu C; McIntyre P
Commun Dis Intell Q Rep; 2008 Jun; 32 Suppl():S2-67. PubMed ID: 18711998
[TBL] [Abstract][Full Text] [Related]
4. Strategies for decision-making on vaccine use: the French experience.
Loulergue P; Floret D; Launay O
Expert Rev Vaccines; 2015 Jul; 14(7):917-22. PubMed ID: 25913015
[TBL] [Abstract][Full Text] [Related]
5. Vaccination of healthcare workers: is mandatory vaccination needed?
Maltezou HC; Theodoridou K; Ledda C; Rapisarda V; Theodoridou M
Expert Rev Vaccines; 2019 Jan; 18(1):5-13. PubMed ID: 30501454
[TBL] [Abstract][Full Text] [Related]
6. Immunosenescence: Implications for vaccination programmes in adults.
Lang PO; Govind S; Michel JP; Aspinall R; Mitchell WA
Maturitas; 2011 Apr; 68(4):322-30. PubMed ID: 21316879
[TBL] [Abstract][Full Text] [Related]
7. Promoting life course vaccination.
Michel JP; Lang PO
Rejuvenation Res; 2011 Feb; 14(1):75-81. PubMed ID: 21208066
[TBL] [Abstract][Full Text] [Related]
8. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia 2006-2010.
Naidu L; Chiu C; Habig A; Lowbridge C; Jayasinghe S; Wang H; McIntyre P; Menzies R
Commun Dis Intell Q Rep; 2013 Dec; 37 Suppl():S1-95. PubMed ID: 24410428
[TBL] [Abstract][Full Text] [Related]
9. Vaccine-preventable diseases in humanitarian emergencies among refugee and internally-displaced populations.
Lam E; McCarthy A; Brennan M
Hum Vaccin Immunother; 2015; 11(11):2627-36. PubMed ID: 26406333
[TBL] [Abstract][Full Text] [Related]
10. Comparison of NITAG policies and working processes in selected developed countries.
Ricciardi GW; Toumi M; Weil-Olivier C; Ruitenberg EJ; Dankó D; Duru G; Picazo J; Zöllner Y; Poland G; Drummond M
Vaccine; 2015 Jan; 33(1):3-11. PubMed ID: 25258100
[TBL] [Abstract][Full Text] [Related]
11. Barriers for vaccination of healthcare workers.
Eltvedt AK; Poulsen A; Winther TN; Von Linstow ML
Hum Vaccin Immunother; 2021 Sep; 17(9):3073-3076. PubMed ID: 33905303
[TBL] [Abstract][Full Text] [Related]
12. Advocating vaccination of adults aged 60 years and older in Western Europe: statement by the Joint Vaccine Working Group of the European Union Geriatric Medicine Society and the International Association of Gerontology and Geriatrics-European Region.
Michel JP; Chidiac C; Grubeck-Loebenstein B; Johnson RW; Lambert PH; Maggi S; Moulias R; Nicholson K; Werner H
Rejuvenation Res; 2009 Apr; 12(2):127-35. PubMed ID: 19415978
[TBL] [Abstract][Full Text] [Related]
13. Dentists' awareness toward vaccine preventable diseases.
Petti S; Messano GA; Polimeni A
Vaccine; 2011 Oct; 29(45):8108-12. PubMed ID: 21856363
[TBL] [Abstract][Full Text] [Related]
14. Adolescents and vaccines in the western world.
Principi N; Esposito S
Vaccine; 2013 Nov; 31(46):5366-74. PubMed ID: 24029116
[TBL] [Abstract][Full Text] [Related]
15. Vaccine preventable diseases and vaccination coverage in Aboriginal and Torres Strait Islander people, Australia, 1999 to 2002.
Menzies R; McIntyre P; Beard F
Commun Dis Intell Q Rep; 2004; 28(2):127-59. PubMed ID: 15460950
[TBL] [Abstract][Full Text] [Related]
16. [Morbidity in vaccine-preventable infections in the Russian Federation and measures aimed at their decrease and eradication].
Onishchenko GG
Zh Mikrobiol Epidemiol Immunobiol; 2003; (2):16-28. PubMed ID: 12886602
[TBL] [Abstract][Full Text] [Related]
17. Introducing new vaccines in developing countries.
Kochhar S; Rath B; Seeber LD; Rundblad G; Khamesipour A; Ali M;
Expert Rev Vaccines; 2013 Dec; 12(12):1465-78. PubMed ID: 24195483
[TBL] [Abstract][Full Text] [Related]
18. Vaccine-preventable outbreaks: still with us after all these years.
Ruderfer D; Krilov LR
Pediatr Ann; 2015 Apr; 44(4):e76-81. PubMed ID: 25875983
[TBL] [Abstract][Full Text] [Related]
19. Measuring vaccine confidence: analysis of data obtained by a media surveillance system used to analyse public concerns about vaccines.
Larson HJ; Smith DM; Paterson P; Cumming M; Eckersberger E; Freifeld CC; Ghinai I; Jarrett C; Paushter L; Brownstein JS; Madoff LC
Lancet Infect Dis; 2013 Jul; 13(7):606-13. PubMed ID: 23676442
[TBL] [Abstract][Full Text] [Related]
20. Rituximab and protection from vaccine preventable diseases: applying the evidence to pediatric patients.
Cheng DR; Barton R; Greenway A; Crawford NW
Expert Rev Vaccines; 2016 Dec; 15(12):1567-1574. PubMed ID: 27216827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
